CN101762478A - Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method - Google Patents
Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method Download PDFInfo
- Publication number
- CN101762478A CN101762478A CN200810235634A CN200810235634A CN101762478A CN 101762478 A CN101762478 A CN 101762478A CN 200810235634 A CN200810235634 A CN 200810235634A CN 200810235634 A CN200810235634 A CN 200810235634A CN 101762478 A CN101762478 A CN 101762478A
- Authority
- CN
- China
- Prior art keywords
- reagent
- homocysteine
- glutamic acid
- acyl
- dish
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a homocysteine diagnosis/determination reagent (kit) using enzyme-colorimetry and enzyme-linked method technology. Meanwhile, the invention also relates to a homocysteine concentration determination method, reagent compositions and components, which belong to the technical filed of medical test and determination. The reagent (kit) of the invention mainly includes: buffer solution, coenzyme, 5-methyltetrahydrofolic pteroyl triglutamic acid, inosine monophosphate, 5-methyltetrahydrofolic pteroyl triglutamic acid-homocysteine-S-methyltransgerase, methionine Gamma-catenase, guanosine monophosphate reductase and stabilizing agent; samples and reagent are mixed according to a certain volume ratio to generate a series of enzymatic reactions; then the reactants are arranged under an ultraviolet/visible light analyzer to detect the increasing degree of absorbance at the 340nm position of a dominant wave so as to measure and calculate the concentration of the homocysteine .
Description
Technical field
The present invention relates to a kind of homocysteine diagnosis/mensuration reagent (box), the invention still further relates to the method for measuring homocysteine concentration simultaneously, belong to medical test determination techniques field.
Background technology
The method of measuring homocysteine in blood plasma has a variety of, comprise high performance liquid chromatography (HPLC), amino-acid analyzer determination method, the chromatography of ions, enzyme-linked immunosorbent assay (EIA), capillary gas chromatography-mass spectrum, fluorescence polarization immunoassay (FPIA), electrochemical process and enzyme process or the like.
1. high performance liquid chromatography (HPLC): be classical reference method, but it has the operation more complicated, test consuming time longly, the shortcoming that the test figure variance ratio is bigger is replaced by enzyme-linked immunosorbent assay, fluorescence polarization assay method and enzyme process aspect clinical practice gradually.High performance liquid chromatography is: use earlier reductive agent to make that the homocysteine of form of ownership is transformed into the reduction form in the blood sample, with the fluorescer generation homocysteine-fluorescent material compound of deriving, the sample after will deriving carries out stratographic analysis then.Absorption affinity difference because of the relative different material of chromatographic stationary, therefore moving phase is also different with its order that elutes, according to this principle separately with the different material in the sample, detect the fluorescence intensity of homocysteine-fluorescent material compound under the wash-out with fluorescence detector, itself and standard items/interior target ratio are compared and calculate, just can measure the level of blood total homocysteine.
2. enzyme-linked immunosorbent assay (EIA): be the common method of measuring homocysteine level clinically, be characterized in operating more convenient, quick, good reproducibility, method is reliable and stable.Shortcoming is most of operation or manual operations, and is more consuming time etc.Its fundamental analysis principle of enzyme-linked immunosorbent assay: use enzyme that the homocysteine of form of ownership in the blood sample is transformed into S-adenosine-L-homocysteine earlier, the monoclonal or the polyclonal antibody that add the anti-S-adenosine of enzyme target-L-homocysteine then, adopt the principle of competition combination, the standard items of varying level are combined with the enzyme labelled antibody competition, with chromogenic reagent with stop reagent and develop the color respectively and stop, produce the typical curve of homocysteine concentration and coloring intensity then.Sample is also handled by same steps as, just can find the concentration of its homocysteine on typical curve.
3. the chromatography of ions: be mainly used in experimental study, less clinically use.Its fundamental analysis principle is a kind of of stratographic analysis, mainly is that its stationary phase adopts ion exchange material, homocysteine can be separated with other material according to its absorption affinity difference to different ions and measure.
4. electrocapillary phoresis method: be mainly used in experimental study, the report in clinical use is arranged.Its characteristics are similar to efficient liquid-phase chromatography method, as it operation more complicated, the test long and bigger shortcoming of test figure variance ratio consuming time arranged.The fundamental analysis principle: use earlier reductive agent to make that the homocysteine of form of ownership is transformed into the reduction form in the blood sample, with the fluorescent reagent generation homocysteine-fluorescent material compound of deriving, the sample after will deriving carries out the electrocapillary phoresis analysis then.Sample is positioned in the high-voltage electric field about 10 kilovolts, because the electrically charged difference of various materials, its isoelectric point is also inequality, therefore its migration velocity in electric field is also just different, homocysteine and other material in the sample can be separated according to this principle, detect the fluorescence intensity of homocysteine-fluorescent material compound again with fluorescence detector, itself and standard items/interior target ratio are compared and calculate, just can measure the level of total homocysteine.
5. fluorescence polarization method: be the reasonable method of measuring homocysteine level clinically, this method full automation instrumental analysis, have fast, accurately, advantage easily.Its fundamental analysis principle: the fluorescence polarization intensity of the homocysteine that free homocysteine and anti-monoclonal antibody combine in the sample is different, sample, standard items are combined with the labeling antibody competition, adopt the principle of competing combination to produce the typical curve of homocysteine concentration and fluorescence polarization intensity, on typical curve, just can find the concentration of its homocysteine.
6. enzyme process: be method of testing of coming out newly developed in response to the market demand, at present domestic have multinomial patented claim: CN98807531.8 to utilize homocysteine to come homocysteine content in the measuring samples; CN200410016789.6 utilizes the cyclic amplification effect of HcyMetase (E.C.2.1.1.10) and S-Adenosylhomocysteine synthase (E.C.3.3.1.1), add adenosine deaminase, purine nucleoside phosphorylase, xanthine oxidase, peroxidase etc., or chromogenic reactions such as adenosine deaminase, hydroxybutyric dehydrogenase (HBD) are measured homocysteine content; CN200510053210.8 utilizes the L-methionine Gamma-catenase to act on and produces fluorescence with fluorescent Compound D MPD2HCl effect again after homocysteine makes it to produce sulfuretted hydrogen, this method is used the test of full-automatic fluorescence analyser, have fast, accurately, advantage easily.Its fundamental analysis principle: with the genetic recombination enzyme homocysteine is decomposed, the sulfuretted hydrogen product that is formed forms the fluorescent chemicals that can measure with fluorescent color-developing agent generation chemical reaction again.
Summary of the invention
The technical problem to be solved in the present invention is: propose a kind of enzymic colorimetric (EnzymaticColorimetric Method) and enzyme (even) united method (Couple Reaction) technology utilized, metering reduced form nicotinamide coenzyme (reduced coenzyme) is in the variation of 340nm wavelength place absorbance, measured the method for homocysteine concentration, simultaneously, the present invention also will provide in order to the homocysteine diagnosis of realizing this method/mensuration reagent (box), adopt this reagent not only can be ultraviolet analyser or half, carry out the homocysteine concentration determination on the automatic clinical chemistry analyzer, and finding speed is fast, the accuracy height, thereby can obtain practical applying.
Homocysteine method for measurement of concentration of the present invention is as follows:
Homocysteine+5-methyl tetrahydro pteroyl three glutamic acid
Methyl tetrahydro pteroyl three glutamic acid-homocysteine S-transmethylase
Tetrahydro pteroyl three glutamic acid+methionine
Methionine+water
Methionine Gamma-catenaseMethyl mercaptan+ammonia+2-ketobutyric acid
Inosine list phosphoric acid+ammonia+coenzyme
Guanosine monophosphate reductaseGuanosine monophosphate+reducibility coenzyme
This method is used 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase (Methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase; EC2.1.1.14) enzyme (idol) connection methionine Gamma-catenase (methionine γ-lyase; EC 4.4.1.11), guanosine monophosphate reductase (GMP reductase; EC 1.7.1.7) enzymatic reaction colorimetric end-point method.5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase enzymolysis homocysteine reaction produces methionine, the effect of uniting methionine Gamma-catenase, guanosine monophosphate reductase again by (idol), coenzyme (not having absorption peak at the 340nm place) reduces the most at last becomes reduced coenzyme (absorption peak being arranged at the 340nm place), thereby measured the degree that reduced coenzyme rises in 340nm place absorbance, by measuring the degree that 340nm place absorbance rises, can calculate the concentration of homocysteine.
Experiment shows, takes all factors into consideration from the accuracy of measurement result and economy two aspects of preparation cost, no matter is single agent, two agent or three doses, and homocysteine diagnosis of the present invention/the mensurations reagent (box) of following composition relation is ideal comparatively:
Damping fluid 100mmol/L
Stabilizing agent 500mmol/L
Coenzyme 3mmol/L
5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase
10000U/L
Methionine Gamma-catenase 12000U/L
Guanosine monophosphate reductase 12000U/L
5-methyl tetrahydrochysene dish acyl three glutamic acid 7mmol/L
Inosine list phosphatase 79 mmol/L
Homocysteine diagnosis of the present invention/mensuration reagent (box) can be single agent, comprising:
Damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid.
Reagent (box) can be dry powder, and use the back that is dissolved in water before use; Also can be mixed with liquid reagent, directly use.
Also above-mentioned single agent reagent can be made into following pair of agent reagent:
Reagent 1
Damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid.
Reagent 2
Damping fluid, stabilizing agent, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase.
Coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, the position of inosine list phosphoric acid in reagent 1 or reagent 2 can not limit.Reagent (box) can be dry powder, and use the back that is dissolved in water before use; Also can be mixed with liquid reagent, directly use.
Above-mentioned single agent reagent can also be made into following three doses of reagent:
Reagent 1
Damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid.
Reagent 2
Damping fluid, stabilizing agent, methionine Gamma-catenase, guanosine monophosphate reductase.
Reagent 3
Damping fluid, stabilizing agent, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase.
Coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, the position of inosine list phosphoric acid in reagent 1, reagent 2 or reagent 3 can not limit.Reagent (box) can be dry powder, and use the back that is dissolved in water before use; Also can be mixed with liquid reagent, directly use.
No matter be single agent, two agent or three doses, the present invention measures the method for homocysteine concentration, and its coenzyme can be NADP
+, NAD
+Or thio-NAD
+In a kind of.
Embodiment
The present invention is further illustrated below in conjunction with examples of implementation.
Embodiment one
The homocysteine diagnosis of present embodiment/mensuration reagent is single reagent, comprising:
Three (ethyloic) aminomethane-hydrochloride buffer 100mmol/L
Stabilizing agent 500mmol/L
Coenzyme 3mmol/L
5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase
10000U/L
Methionine Gamma-catenase 12000U/L
Guanosine monophosphate reductase 12000U/L
5-methyl tetrahydrochysene dish acyl three glutamic acid 7mmol/L
Inosine list phosphatase 79 mmol/L
Reagent divides the bottle of packing into after all dissolving and preparing, and carries out freeze drying, makes powdered reagent; Before the use, add pure water, use after redissolving.
On automatic clinical chemistry analyzer, set: 37 ℃ of temperature, 10 minutes reaction time, initial absorbance≤0.1, test predominant wavelength 340nm, test commplementary wave length 405nm, the volume ratio of tested homocysteine sample and reagent is 1/25, the Direction of Reaction is positive reaction (reaction of rising), about about 0 minute of time delay is about 5 minutes detection times.
After adding sample and reagent, make them mixed and have reaction, reactant places under the Biochemical Analyzer the most at last, detects the degree that predominant wavelength 340nm absorbance rises, thereby calculates the concentration of homocysteine.
Embodiment two
The homocysteine diagnosis of present embodiment/mensuration reagent is double reagent, comprising:
Reagent 1
Three (ethyloic) aminomethane-hydrochloride buffer 100mmol/L
Stabilizing agent 50mmol/L
Coenzyme 3mmol/L
5-methyl tetrahydrochysene dish acyl three glutamic acid 7mmol/L
Inosine list phosphatase 79 mmol/L
Reagent 2
Three (ethyloic) aminomethane-hydrochloride buffer 100mmol/L
Stabilizing agent 50mmol/L
5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase
10000U/L
Methionine Gamma-catenase 12000U/L
Guanosine monophosphate reductase 12000U/L
Reagent divides the bottle of packing into after all dissolving and preparing, and makes liquid double reagent, can directly use.
On automatic clinical chemistry analyzer, set: 37 ℃ of temperature, 10 minutes reaction time, initial absorbance≤0.1, test predominant wavelength 340nm, test commplementary wave length 405nm, the volume ratio of tested homocysteine sample and reagent 1, reagent 2 is 2/20/5, the Direction of Reaction is positive reaction (reaction of rising), about about 0 minute of time delay is about 5 minutes detection times.
After adding sample and reagent, make them mixed and have reaction, reactant places under the Biochemical Analyzer the most at last, detects the degree that predominant wavelength 340nm absorbance rises, thereby calculates the concentration of homocysteine.
Embodiment three
The homocysteine diagnosis of present embodiment/mensuration reagent is three reagent, comprising:
Reagent 1
Three (ethyloic) aminomethane-hydrochloride buffer 100mmol/L
Stabilizing agent 50mmol/L
Coenzyme 3mmol/L
5-methyl tetrahydrochysene dish acyl three glutamic acid 7mmol/L
Inosine list phosphatase 79 mmol/L
Reagent 2
Three (ethyloic) aminomethane-hydrochloride buffer 100mmol/L
Stabilizing agent 500mmol/L
Methionine Gamma-catenase 12000U/L
Guanosine monophosphate reductase 12000U/L
Reagent 3
Three (ethyloic) aminomethane-hydrochloride buffer 100mmol/L
Stabilizing agent 500mmol/L
5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase
10000U/L
Reagent divides the bottle of packing into after all dissolving and preparing, and makes liquid three reagent, can directly use.
When measuring homocysteine concentration, on automatic clinical chemistry analyzer, set: 37 ℃ of temperature, 10 minutes reaction time, initial absorbance≤0.1, test predominant wavelength 340nm, test commplementary wave length 405nm, the volume ratio of tested homocysteine sample and reagent 1, reagent 2, reagent 3 is 4/40/5/5, the Direction of Reaction is positive reaction (reaction of rising), and about about 0 minute of time delay is about 5 minutes detection times.
After adding sample and reagent, make them mixed and have reaction, reactant places under the Biochemical Analyzer the most at last, detects the degree that predominant wavelength 340nm absorbance rises, thereby calculates the concentration of homocysteine.
The applicant adopts other assay methods of putting down in writing in the above summary of the invention all can reach purpose of the present invention through experimental verification, in view of situation such as determination step and above embodiment roughly the same, do not separately enumerate.
In a word, experimental results show that: adopt assay method of the present invention can draw required measurement result by general biochemical analyzer fully---the blank reagent absorbance changes (Δ A/min)≤0.001; Absorbance time response curve should be the rising curve until terminal point; Reagent can be surveyed effectively, and (R 〉=0.99) linear range can reach 600 μ mol/L; The inaccuracy of reagent test, its relative deviation be no more than ± and 4%; The coefficient of variation (CV)≤2% of the precision of reagent test (repeatability); The sensitivity of reagent can reach 0.0003 ± 0.0002 Δ A/ μ mol/L; Reagent is preserved down at 2-8 ℃, and activity can be stablized 1 year;---the present invention is highly sensitive, degree of accuracy good, the linear range broadness, and stationary phase is long, is enough to easy to utilize.
Claims (6)
1. the method for measurement of concentration of the homocysteine of enzymic colorimetric and enzyme-linked method, its method is as follows:
Homocysteine+5-methyl tetrahydro pteroyl three glutamic acid
Methyl tetrahydro pteroyl three glutamic acid-homocysteine S-transmethylase
Tetrahydro pteroyl three glutamic acid+methionine
Methionine+water
Methionine Gamma-catenaseMethyl mercaptan+ammonia+2-ketobutyric acid
Inosine list phosphoric acid+ammonia+coenzyme
Guanosine monophosphate reductaseGuanosine monophosphate+reducibility coenzyme
The end reaction thing is placed under ultraviolet analyser or half, the automatic clinical chemistry analyzer, detect the degree that predominant wavelength 340nm absorbance rises, calculate the concentration measurement result of homocysteine.
2. homocysteine diagnosis/mensuration reagent (box), principal ingredient comprises:
Damping fluid 20---500mmol/L
Stabilizing agent 1---4000mmol/L
DPN diphosphopyridine nucleotide---6mmol/L
5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase
1000——80000U/L
Methionine Gamma-catenase 1000---80000U/L
Guanosine monophosphate reductase 1000---80000U/L
5-methyl tetrahydrochysene dish acyl three glutamic acid 1---50mmol/L
Inosine list phosphatase 11---50mmol/L
The concentration of reagent composition not necessarily is only limited to above-mentioned scope; Effect is better in this scope, and outside this scope, reagent still can reagentia.
It is characterized in that: reagent (box) can be dry powder, and use the back that is dissolved in water before use; Also can be mixed with liquid reagent, directly use.
3. according to the described homocysteine diagnosis of claim 2/mensuration reagent (box), it is characterized in that:
Form single agent reagent by damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid.
4. according to the described homocysteine diagnosis of claim 2/mensuration reagent (box), it is characterized in that:
Form two agent reagent by damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid; Reagent 1 is made up of damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid; Reagent 2 is made up of damping fluid, stabilizing agent, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase.Coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, the position of inosine list phosphoric acid in reagent 1 or reagent 2 can not limit.
5. according to the described homocysteine diagnosis of claim 2/mensuration reagent (box), it is characterized in that:
Form multi-agent reagent by damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid; Reagent 1 is made up of damping fluid, stabilizing agent, coenzyme, 5-methyl tetrahydrochysene dish acyl three glutamic acid, inosine list phosphoric acid; Reagent 2 is made up of damping fluid, stabilizing agent, methionine Gamma-catenase, guanosine monophosphate reductase; Reagent 3 is made up of damping fluid, stabilizing agent, 5-methyl tetrahydrochysene dish acyl three glutamic acid-homocysteine-S-transmethylase.Coenzyme, 5-methyl tetrahydrochysene dish acyl three propylhomoserins-homocysteine-S-transmethylase, methionine Gamma-catenase, guanosine monophosphate reductase, 5-methyl tetrahydrochysene dish acyl three glutamic acid, the position of inosine list phosphoric acid in reagent 1, reagent 2 or reagent 3 can not limit.
6. according to the described homocysteine diagnosis of claim 2/mensuration reagent (box), it is characterized in that: also comprise stabilizing agent 1-4000mmol/L or 0.1%-100% volume ratio.Described stabilizing agent is: glycerine (Glycerol), propylene glycol (Propylene Glycol), ethylene glycol (Ethylene glycol) and at least one of the preservatives.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810235634A CN101762478A (en) | 2008-12-10 | 2008-12-10 | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810235634A CN101762478A (en) | 2008-12-10 | 2008-12-10 | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101762478A true CN101762478A (en) | 2010-06-30 |
Family
ID=42493769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810235634A Pending CN101762478A (en) | 2008-12-10 | 2008-12-10 | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101762478A (en) |
-
2008
- 2008-12-10 CN CN200810235634A patent/CN101762478A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101762517A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101750392A (en) | Homocysteine diagnosing/measuring reagent (kit) and homocysteine concentration measuring method | |
| CN101762523A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762479A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762518A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762525A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762522A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101750356A (en) | Homocysteine diagnosing/measuring reagent (kit) and homocysteine concentration measuring method | |
| CN101762550A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762509A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101750298A (en) | Homocysteine diagnosing/measuring reagent (kit) and homocysteine concentration measuring method | |
| CN101762478A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762512A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101750395A (en) | Homocysteine diagnosing/measuring reagent (kit) and homocysteine concentration measuring method | |
| CN101762553A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method-982 | |
| CN101762477A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762476A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762519A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101750302A (en) | Homocysteine diagnosing/measuring reagent (kit) and homocysteine concentration measuring method | |
| CN101762524A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762549A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101609015A (en) | The method for measurement of concentration of homotype semicystionl diagnostic kit and homocysteine | |
| CN101762474A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101762465A (en) | Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method | |
| CN101620174A (en) | The method for measurement of concentration of homotype semicystionl diagnostic kit and homocysteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Erzhong Document name: Notification of Publication of the Application for Invention |
|
| DD01 | Delivery of document by public notice |
Addressee: Aijie Biological Science & Technology Co., Ltd., Suzhou City Wang Erzhong Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100630 |